Literature DB >> 28584511

An Evaluation of Intra- and Post-operative Blood Loss in Total Hip Arthroplasty at the National Orthopaedic Hospital, Lagos.

Michael Ebiyon Ugbeye1, Wakeel Olaide Lawal1, Olusegun John Ayodabo1, Ine Prattson Adadevoh1, Imeh James Akpan1, Uche Nwose1.   

Abstract

BACKGROUND: Severe hip pain with associated significant functional limitation is the major indication for total hip replacement, a rewarding and gratifying procedure. However, significant blood loss can occur in the intra- and post-operative periods, posing a major challenge and necessitating prompt restoration of circulating blood volume to minimize morbidity and mortality. The aim of this study was to evaluate blood loss after primary total hip replacement, and to determine the effect of surgical time on blood loss. PATIENTS AND METHODS: A prospective study of blood loss after total hip arthroplasty in 41 patients. All cases were primary total hip arthroplasty done by one surgeon. Intra- and post-operative blood losses were recorded in two groups of patients (surgical time <2 h and surgical time >2 h), and the effect of these on blood loss was evaluated.
RESULTS: The mean intra- and post-operative blood losses were 1222.7 ml and 574.3 ml, respectively. These showed a strong positive correlation with total blood loss (r = 0.790, P < 0.001 and r = 0.517, P < 0.001). Higher intra- and post-operative blood losses were recorded in patients with surgical time >2 h, with a significant difference on postoperative days 2 and 3 (P = 0.003 and P = 0.014, respectively).
CONCLUSION: Blood loss in total hip replacement is an important factor and may be influenced by a shorter surgical time.

Entities:  

Keywords:  Blood loss; primary total hip arthroplasty; surgical time

Year:  2017        PMID: 28584511      PMCID: PMC5441215          DOI: 10.4103/1117-6806.205750

Source DB:  PubMed          Journal:  Niger J Surg        ISSN: 1117-6806


Introduction

Total hip replacement is a rewarding and reliable procedure in patients with severe hip pain associated with functional limitation. The benefits of the procedure are gratifying in the elderly and young patient, particularly if patient selection is appropriate and ideal. The procedure, however, may be associated with significant blood loss, especially in revision and complex cases, necessitating prompt restoration of circulating blood volume. This in itself poses a danger, as the risks of homologous blood transfusion cannot be over emphasized.[1234] Measures to minimize intra-operative blood loss including optimal preoperative physiological status, use of appropriate surgical approach, gentle and delicate tissue dissection, surgical expertise, rational use of electrocautery, and others should be employed during this procedure. Studies have shown a reduction in blood loss after the use of a posterior approach in total hip replacement.[567] Others have emphasized the benefits of surgical time <90 min in reducing blood loss;[7] however, speed should not substitute good surgical acumen and gentle tissue dissection. The role of autologous blood transfusion, deliberate hypotension, and administration of fibrinolytic inhalators in reducing blood loss was emphasized by Bannister et al.[8] Other researchers have investigated the role of tranexamic acid in minimizing intra- and post-operative blood loss.[9101112] The hypothesis of this study is that reduced surgical time has no significant benefit in minimizing blood loss, if surgical principles are strictly followed.

Objectives

To evaluate blood loss after total hip replacement To evaluate the effect of surgical time on blood loss.

Patients and Methods

Study design

A prospective study of blood loss after total hip arthroplasty in 41 patients in the National Orthopaedic Hospital, Lagos, between January 2013 and December 2014.

Inclusion criteria

Patients with no previous thromboembolic phenomenon Patients with no renal pathology Patients with no hepatic pathology Patients that gave consent for inclusion in the study.

Exclusion criteria

History of bleeding disorder Patients on anticoagulants for established venous thromboembolism Patients with renal pathology Patients with hepatic pathology Patients that do not give consent for inclusion in the study Revision and complex primary total hip replacement.

Study technique

Approval for the study was obtained from the Ethics and Research Committee of the Hospital, following development of a study protocol. Consecutive patients with established indications, presenting for total hip arthroplasty were recruited into the study after obtaining their consent. Patients’ demographic parameters, complaints, and associations, diagnosis, surgical approach, type of anesthesia, pre- and post-operative hemoglobin concentration, duration of surgery, intra- and post-operative blood loss, and a number of blood units transfused were recorded on the designed pro forma. As part of the study protocol, preliminary estimation of blood volume in a partially and fully soaked gauze pack (abdominal pack) and swab was done by weighing the wet and dry gauze pack and swabs and subtracting the values of dry weight from wet weight as shown in Table 1.
Table 1

Volume of blood loss into swabs and gauze packs

Volume of blood loss into swabs and gauze packs Surgery was done under regional or general anesthesia using either the direct lateral or posterior approach. All procedures were done under strict asepsis by the same surgeon; while ensuring dissection along surgical planes, judicious use of electrocautery and gentle soft tissue dissection. A Redivac suction drain was used for all patients. Intraoperative blood loss was calculated by counting the number of swabs and gauze packs and estimating the volume of blood as shown in Table 1. Blood loss was also measured by calculating the amount of blood in the suction, after subtracting the volume of irrigation fluid used; blood loss on the drapes was also estimated. The total intraoperative blood loss is obtained by summation of blood loss to all these points. Postoperative blood loss was calculated by measuring the blood volume within the closed suction reservoir bottle within the first 72 h. The effect of surgical time on blood loss was evaluated by dividing patients into two groups, based on the surgical time. Group 1 patients had surgical time <2 h, whereas Group 2 patients had surgical time >2 h.

Statistical analysis

Data were collected and summarized on a spreadsheet and analyzed using the Statistical Package for the Social Sciences version 17 (SPSS Inc., Chicago, IL). Statistical significance of tested variables was assessed using the independent t-test and Levene's test for equality of variances. P =0.05 or less was taken as significant, at 95% confidence interval.

Outcome measure

The outcome measures were intra- and post-operative blood loss after total hip replacement.

Results

A total of 41 patients who had total hip arthroplasty were studied. Age range was between 18 and 81 years, with a mean age of 45.6 ± 15.8 years. Male patients accounted for 36.6% of cases and females 63.4%, giving a male: female ratio of 1:1.7. The average duration of symptoms was 3.8 years, with bilateral pathology in 27.9% of patients. Twenty-one patients (51.2%) had a right total hip arthroplasty, whereas twenty patients (48.8%) had left total hip arthroplasty. Fourteen patients (32.6%) had associated hemoglobinopathy. All patients had a primary total hip replacement. The direct lateral approach was used in 23 (56.1%) patients, whereas 18 (43.9%) patients had a posterior approach. The average duration of surgery was 2.3 ± 0.5 h, with 18 (43.9%) of procedures done within 2 h and 23 (56.1%) lasting over 2 h. The results of pre- and post-operative parameters and blood loss are shown in the charts and tables below. The average pre- and post-operative hemoglobin concentrations were 11.4 ± 1.9 g/dl and 9.4 ± 1.4 g/dl, respectively [Figures 1 and 2]. The mean hemoglobin loss was 2.1 ± 1.1 g/dl (r = 0.82, P < 0.001).
Figure 1

Pre-operative Heamoglobin Concentration

Figure 2

Post-operative Heamoglobin Concentration

Pre-operative Heamoglobin Concentration Post-operative Heamoglobin Concentration The mean intraoperative blood loss was 1222.7 ± 334.7 ml, with a range of 450–1900 ml [Figure 3]. Thirty-seven patients (90.2%) had intraoperative blood transfusion, with 80.5% of patients receiving at least two pints of blood [Table 2]. The mean postoperative blood loss and total blood loss were 574.3 ml and 1786.2 ml, respectively, showing a strong positive correlation (r = 0.517, P < 0.01). Intraoperative blood loss also showed a strong positive correlation with total blood loss (r = 0.790, P < 0.01).
Figure 3

Intra-operative Blood loss

Table 2

Volume of blood transfused intraoperatively (pints)

Intra-operative Blood loss Volume of blood transfused intraoperatively (pints) The postoperative blood loss measured as drain effluent volume within the first 72 h, is shown in Table 3; the average duration of drain use is also shown. The results of intra- and post-operative blood loss in the two groups of patients are shown in Tables 4 and 5, as assessed by the independent t-test.
Table 3

Postoperative blood loss as measured by drain effluent within first 72 h

Table 4

Independent t-test for two groups

Table 5

Independent samples t-test for equality of means

Postoperative blood loss as measured by drain effluent within first 72 h Independent t-test for two groups Independent samples t-test for equality of means

Discussion

Blood loss in total hip arthroplasty remains a challenge, as efforts are constantly being made to minimize the rate of loss, rate of replacement, and the associated morbidity and mortality that follow blood loss and blood transfusion.[1234] This study evaluates blood loss following total hip arthroplasty and considers the effect of surgical time on intra- and post-operative blood loss. The mean surgical time was 2.3 ± 0.5 h, which was higher than that described by Flordal and Neander,[7] (89 min) and Miao et al.[13] (88 ± 26 min). However, 43.9% of patients in this study had surgical time <2 h. The mean intraoperative blood loss was 1222.7 ml, which is 12.2% and 197.3% higher than that described by Flordal and Neander[7] (1090 ml) and Miao et al.[13] (411 ml), respectively. This is also reflected in the mean total blood loss of 1155 ml reported by Miao et al., as opposed to 1786.2 ml in this study; other authors have reported a mean total blood loss ranging from 1023 to 1785 ml.[41415] The mean postoperative blood loss reduced steadily from day 1 to day 3, with an average of 407.1 ml on day 1 and 21.4 ml on day 3. The average duration of drain use was 2.5 ± 0.5 days. The intra- and post-operative blood loss both showed a positive correlation with the total blood loss in this series and is also a reflection of the significant decline in hemoglobin concentration postoperatively with an average of 2.1 ± 1.1 g/dl (r = 0.82, P < 0.001). Surgical time >2 h showed a higher intra- and post-operative blood loss, compared to surgical time <2 h. This difference was significant in postoperative blood loss on days 2 and 3, when equal variances are assumed (P = 0.003 and P = 0.014), with lower values in surgical time <2 h.

Conclusion

A reduction in surgical time <2 h has a role in minimizing blood loss, especially in the postoperative period. The tested hypothesis is, therefore, rejected.

Limitations

Limited number of cases done yearly, which was also the basis of our sample size calculation No Control group was used in this study to determine other factors that may affect blood loss. However, the authors are currently evaluating the effect of tranexamic acid on blood loss in total hip replacement with this study as a control.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  15 in total

1.  Predicting need for allogeneic transfusion after total knee arthroplasty.

Authors:  Manish S Noticewala; Jonathan D Nyce; Wenbao Wang; Jeffrey A Geller; William Macaulay
Journal:  J Arthroplasty       Date:  2012-06       Impact factor: 4.757

2.  Does blood transfusion increase the risk of infection after hip fracture?

Authors:  K J Koval; A D Rosenberg; J D Zuckerman; G B Aharonoff; M L Skovron; R L Bernstein; E Su; M Chakka
Journal:  J Orthop Trauma       Date:  1997-05       Impact factor: 2.512

3.  Blood loss in cemented THA is not reduced with postoperative versus preoperative start of thromboprophylaxis.

Authors:  Pål O Borgen; Ola E Dahl; Olav Reikerås
Journal:  Clin Orthop Relat Res       Date:  2012-04-03       Impact factor: 4.176

4.  A clinical comparison of the anterolateral and posterolateral approaches to the hip.

Authors:  M A Ritter; L D Harty; M E Keating; P M Faris; J B Meding
Journal:  Clin Orthop Relat Res       Date:  2001-04       Impact factor: 4.176

5.  Comparison of the transtrochanteric and posterior approaches for total hip replacement.

Authors:  R P Robinson; H J Robinson; E A Salvati
Journal:  Clin Orthop Relat Res       Date:  1980 Mar-Apr       Impact factor: 4.176

Review 6.  Antifibrinolytics in major orthopaedic surgery.

Authors:  Jason David Eubanks
Journal:  J Am Acad Orthop Surg       Date:  2010-03       Impact factor: 3.020

7.  Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties.

Authors:  K Ido; M Neo; Y Asada; K Kondo; T Morita; T Sakamoto; R Hayashi; S Kuriyama
Journal:  Arch Orthop Trauma Surg       Date:  2000       Impact factor: 3.067

Review 8.  Blood loss in total hip replacement. A retrospective study.

Authors:  P A Flordal; G Neander
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

9.  Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.

Authors:  G Benoni; H Fredin
Journal:  J Bone Joint Surg Br       Date:  1996-05

10.  Hidden blood loss and its influential factors after total hip arthroplasty.

Authors:  Kaisong Miao; Su Ni; Xianju Zhou; Nanwei Xu; Rongbin Sun; Chao Zhuang; Yuji Wang
Journal:  J Orthop Surg Res       Date:  2015-03-18       Impact factor: 2.359

View more
  1 in total

1.  Role of arthroplasty in the Jehovah's Witness population.

Authors:  Jay L Mottla; Jordan P Murphy; Laura E Keeling; Richard Verstraete; Mark W Zawadsky
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-01-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.